Inexpensive Catalysis Incorporates Methane Into Larger Molecules
Stasik Popov, Alex Bagdasarian, Hosea Nelson and Brian Chao. UCLA
When scientists develop the chemical formulas for new products such as fuels and medications, they often must first create molecules that haven't previously existed.
A basic step toward creating new molecules is selectively breaking and re-forming the chemical bonds that connect the atoms that make them up. One of the chief challenges is that the bond between carbon and hydrogen atoms -- the building blocks of many molecules -- is exceptionally strong, so chemists often have to resort to using rare and expensive chemicals like iridium to convert it into other, more useful types of chemical bonds. Scientists refer to this process as "functionalizing" the bonds.
Now, a team of UCLA chemists has developed a new technique for breaking carbon-hydrogen bonds and making carbon-carbon bonds. The approach uses catalysts made of two abundant and inexpensive elements, silicon and boron. Their research was published in Science.
Hosea Nelson, a UCLA assistant professor of chemistry and biochemistry and senior author of the study, said the energy industry has been interested in taking very simple hydrocarbon molecules like methane and turning them into new fuels.
"This new method will enable scientists to incorporate methane into bigger molecules," he said.
Another potential application would be converting methane, one of the primary components of natural gas, into something that's denser and easier to contain after it has been drilled from the Earth. The current process is complicated because methane, a light gas, tends to escape into the atmosphere.
Nelson collaborated on the study with UCLA graduate students Brian Shao, Alex Bagdasarian and Stasik Popov.
The researchers used their new technique to create a compound similar to a phenyl cation, a chemical substance that has been studied theoretically but rarely investigated in actual laboratory experiments. They then used the compound to slice through carbon-hydrogen bonds in methane and benzene, which allowed them to insert other atoms and form carbon-carbon bonds, which are the basic building blocks of molecules that make up living organisms, as well as fuels and pharmaceuticals.
Besides demonstrating that phenyl cation-like compounds exist, the new technique allows complex molecules to be assembled in far fewer reaction steps than was previously possible, which could save chemical and pharmaceutical manufacturers time and money. Another advantage of the method is that, unlike previous approaches, it can be performed at temperatures and gas pressures that are easily attainable in a laboratory.
The process could also be used to alter the molecules in existing pharmaceuticals to make them more effective, safer or less addictive.
The chemists have tested their technique using very small samples of reactants -- far less than a gram. But Nelson is hopeful that the methodology can be scaled up to be useful for a broad range of real-world chemical reactions.
Shao, B., Bagdasarian, A., Popov, S. and Nelson, H. (2017). Arylation of hydrocarbons enabled by organosilicon reagents and weakly coordinating anions. Science, 355(6332), pp.1403-1407.
This article has been republished from materials provided by UCLA. Note: material may have been edited for length and content. For further information, please contact the cited source.
Chemicals in Lavender and Tea Tree Oil Could be Hormone DisruptorsNews
A new study lends further evidence to a suspected link between abnormal breast growth in young boys--called prepubertal gynecomastia--and regular exposure to lavender or tea tree oil, by finding that key chemicals in these common plant-derived oils act as endocrine-disrupting chemicals.READ MORE
Huntsman Cancer Institute Joins National Clinical Trial Targeting AMLNews
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.READ MORE
3-D Tissue Model of Developing Heart Could Aid Drug Safety Testing for Pregnant WomenNews
The heart is the first organ to develop in the womb and the first cause of concern for many parents. Parents and doctors often have to consider the mother's health as well as the potential risk regarding how medication could affect their baby."We can try to rebuild the shape of the early development heart in the lab," said Professor Zhen Ma. "It mimics the very early stage, during the embryo genesis - how the heart was formed."READ MORE
Comments | 0 ADD COMMENT
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
World Congress on Advances in Addiction Science and Medicine
Sep 24 - Sep 25, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018